oseltamivir has been researched along with Chronic Disease in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (33.33) | 29.6817 |
2010's | 5 (55.56) | 24.3611 |
2020's | 1 (11.11) | 2.80 |
Authors | Studies |
---|---|
Martins, J; Monteiro, A; Ribeiro, L | 1 |
Garnacho-Montero, J; Granada, R; Gutiérrez-Pizarraya, A; Màrquez, JA; Rello, J; Rodríguez, A; Ruiz-Santana, S; Zaragoza, R | 1 |
Chen, YS; Lan, CC; Liu, CC | 1 |
Blumentals, WA; Piedra, PA; Schulman, KL | 1 |
Alioglu, B; Dallar, Y; Ozen, C; Selver, B; Tasar, A | 1 |
Feng, L; Feng, Y; Feng, Z; Gao, Z; Gargiullo, P; Huai, Y; Jiang, H; Liao, Q; Peng, Z; Shu, Y; Uyeki, TM; Wang, Y; Xiang, N; Xu, C; Yang, W; Ye, M; Yu, H; Yuan, Y; Zhang, Y; Zheng, J; Zheng, Y; Zhou, L | 1 |
Watanabe, A | 1 |
Bonmarin, I; Desenclos, JC; Doyle, A; Le Strat, Y; Lévy-Bruhl, D | 1 |
Gyldmark, M; Novak, A; Postma, MJ; Scheijbeler, HW; van Genugten, ML; Wilschut, JC | 1 |
1 trial(s) available for oseltamivir and Chronic Disease
Article | Year |
---|---|
A randomized double-blind controlled study of laninamivir compared with oseltamivir for the treatment of influenza in patients with chronic respiratory diseases.
Topics: Adult; Aged; Antiviral Agents; Asthma; Chronic Disease; Double-Blind Method; Enzyme Inhibitors; Female; Guanidines; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Male; Middle Aged; Neuraminidase; Oseltamivir; Pyrans; Sialic Acids; Treatment Outcome; Zanamivir | 2013 |
8 other study(ies) available for oseltamivir and Chronic Disease
Article | Year |
---|---|
Hyperacute relapse of Lewis-Sumner syndrome during influenza A (H1N1) virus infection.
Topics: Antiviral Agents; Chronic Disease; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Magnetic Resonance Imaging; Male; Middle Aged; Oseltamivir; Polyradiculoneuropathy, Chronic Inflammatory Demyelinating; Recurrence; Syndrome | 2020 |
Epidemiology, clinical features, and prognosis of elderly adults with severe forms of influenza A (H1N1.
Topics: Age Distribution; Aged; Antiviral Agents; Case-Control Studies; Chronic Disease; Comorbidity; Female; Humans; Incidence; Influenza A Virus, H1N1 Subtype; Influenza, Human; Intensive Care Units; Logistic Models; Male; Multivariate Analysis; Oseltamivir; Prognosis; Prospective Studies; Spain; Survival Analysis | 2013 |
Acute exacerbation of psychiatric symptoms during influenza treatment with oseltamivir in chronic schizophrenia.
Topics: Adult; Aged; Antiviral Agents; Chronic Disease; Humans; Influenza, Human; Male; Oseltamivir; Schizophrenia | 2015 |
Effects of oseltamivir on influenza-related complications in children with chronic medical conditions.
Topics: Adolescent; Antiviral Agents; Child; Child, Preschool; Chronic Disease; Female; Hospitalization; Humans; Infant; Influenza, Human; Lung Diseases; Male; Oseltamivir; Otitis Media; Proportional Hazards Models; Retrospective Studies | 2009 |
An experience of oseltamivir phosphate (tamiflu™) in a pediatric patient with chronic idiopathic thrombocytopenic purpura: a case report.
Topics: Adolescent; Antiviral Agents; Chronic Disease; Female; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Oseltamivir; Platelet Count; Purpura, Thrombocytopenic, Idiopathic | 2010 |
Risk factors for severe illness with 2009 pandemic influenza A (H1N1) virus infection in China.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiviral Agents; Child; Child, Preschool; China; Chronic Disease; Female; Hospitalization; Humans; Infant; Infant, Newborn; Influenza A Virus, H1N1 Subtype; Influenza, Human; Male; Middle Aged; Obesity; Oseltamivir; Pregnancy; Risk Factors; Young Adult | 2011 |
Influenza pandemic preparedness in France: modelling the impact of interventions.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiviral Agents; Child; Child, Preschool; Chronic Disease; Computer Simulation; Disease Outbreaks; Female; France; Hospitalization; Humans; Infant; Infant, Newborn; Influenza Vaccines; Influenza, Human; Male; Middle Aged; Models, Theoretical; Oseltamivir | 2006 |
Cost effectiveness of oseltamivir treatment for patients with influenza-like illness who are at increased risk for serious complications of influenza: illustration for the Netherlands.
Topics: Aged; Antiviral Agents; Chronic Disease; Cost of Illness; Cost-Benefit Analysis; Female; Humans; Influenza, Human; Male; Models, Economic; Netherlands; Oseltamivir; Risk | 2007 |